Investors
News & Events
Contact Us
Home
Who We Are
Company Overview
Management Team
Board of Directors
Partners
Pipeline
Clinical Programs
IRAK1/4
RIPK1
Partnered Programs
Clinical Trials
Investigator Sponsored Research
Expanded Access Policy
Products
Join Our Team
Life at Rigel
Our Values
Benefits
Current Openings
Investors
News & Events
Contact Us
Press Releases
Investors
Investors
Overview
News & Events
Press Releases
Events & Presentations
Email Alerts
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
FAQ
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Analyst Coverage
Governance
Management Team
Board of Directors
Board Committees
Governance Documents
News & Events
Press Releases
Events & Presentations
Email Alerts
Year
All Years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Category
All Releases
Financial Releases
Search terms
Search News
Jun 10, 2009 7:30am EDT
Rigel to Present at Jefferies Healthcare Conference
Jun 01, 2009 7:30am EDT
Rigel's R788 Evaluated in Phase 2 Trial in Multiple Cancers
May 13, 2009 7:30am EDT
Rigel to Present at JMP Securities Research Conference
May 05, 2009 7:00am EDT
Rigel Announces First Quarter 2009 Financial Results
Feb 24, 2009 6:00am EST
Rigel Announces Fourth Quarter and Year End 2008 Financial Results
Feb 05, 2009 7:30am EST
Rigel to Present at BIO CEO & Investor Conference
Feb 03, 2009 6:00am EST
Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
Feb 02, 2009 6:00pm EST
Rigel to Host Conference Call on February 3, 2009
Jan 23, 2009 7:30am EST
Rigel to Present at Keystone Symposia Conference
Dec 08, 2008 7:30am EST
Rigel to Participate at the RBC Capital Markets Healthcare Conference
Previous
1…
32
33
34
35
36
37
38
39
40
41
…43
Next
Email Alerts
RSS News Feed
